Baotou Dongbao Bio-Tech Co Ltd (300239) — Net Asset Quality Index
Baotou Dongbao Bio-Tech Co Ltd (300239) has a Net Asset Quality Index of 67.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.57 Billion minus total liabilities of CN¥831.08 Million yields net assets of CN¥1.74 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Baotou Dongbao Bio-Tech Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Baotou Dongbao Bio-Tech Co Ltd Net Asset Quality Index Over Time (2008–2025)
This chart shows how Baotou Dongbao Bio-Tech Co Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 67.7%, representing net assets of CN¥1.74 Billion against total assets of CN¥2.57 Billion CNY. For live market cap and overall valuation, see Baotou Dongbao Bio-Tech Co Ltd market cap and net worth.
Annual Net Asset Quality Index for Baotou Dongbao Bio-Tech Co Ltd (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 300239 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.6% | CN¥1.72 Billion | CN¥2.55 Billion | CN¥826.49 Million | ▲ +1.3 pp |
| 2024 | 66.3% | CN¥1.74 Billion | CN¥2.62 Billion | CN¥885.50 Million | ▼ -2.8 pp |
| 2023 | 69.0% | CN¥1.89 Billion | CN¥2.74 Billion | CN¥848.82 Million | ▼ -7.0 pp |
| 2022 | 76.1% | CN¥1.76 Billion | CN¥2.31 Billion | CN¥552.26 Million | ▲ +0.2 pp |
| 2021 | 75.9% | CN¥1.60 Billion | CN¥2.11 Billion | CN¥508.58 Million | ▲ +5.5 pp |
| 2020 | 70.4% | CN¥998.18 Million | CN¥1.42 Billion | CN¥419.75 Million | ▼ -5.1 pp |
| 2019 | 75.5% | CN¥991.86 Million | CN¥1.31 Billion | CN¥322.48 Million | ▲ +12.8 pp |
| 2018 | 62.6% | CN¥750.88 Million | CN¥1.20 Billion | CN¥447.86 Million | ▼ -12.5 pp |
| 2017 | 75.1% | CN¥729.75 Million | CN¥971.54 Million | CN¥241.78 Million | ▼ -11.2 pp |
| 2016 | 86.3% | CN¥718.86 Million | CN¥833.13 Million | CN¥114.27 Million | ▼ -4.3 pp |
| 2015 | 90.6% | CN¥706.55 Million | CN¥780.04 Million | CN¥73.50 Million | ▲ +26.4 pp |
| 2014 | 64.2% | CN¥340.56 Million | CN¥530.57 Million | CN¥190.01 Million | ▼ -3.5 pp |
| 2013 | 67.6% | CN¥351.47 Million | CN¥519.63 Million | CN¥168.16 Million | ▲ +0.9 pp |
| 2012 | 66.8% | CN¥324.03 Million | CN¥485.26 Million | CN¥161.23 Million | ▼ -11.6 pp |
| 2011 | 78.4% | CN¥295.99 Million | CN¥377.62 Million | CN¥81.63 Million | ▲ +22.7 pp |
| 2010 | 55.6% | CN¥122.44 Million | CN¥220.06 Million | CN¥97.62 Million | ▲ +7.1 pp |
| 2009 | 48.6% | CN¥100.65 Million | CN¥207.25 Million | CN¥106.60 Million | ▼ -0.3 pp |
| 2008 | 48.9% | CN¥97.87 Million | CN¥200.11 Million | CN¥102.24 Million | — |